CST will reap the benefits of the larger than expected marketing expenditure. I think getting the automated test into the major labs would have required a fair bit of "incentive" marketing (e.g. subsidising computing and other hardware). Just guessing!
I'm happy with the dividend (it is a start) as a holder with a longer term view.